Definium Therapeutics remote work and careers
Precise science. Boundless impact.
About Definium Therapeutics
Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one, we have been powered by a radical idea: treatments for anxiety and depression should bring real relief. Together we’re moving psychiatry forward— beyond better, into a boundless future. Definium Therapeutics trades on the NASDAQ under the symbol DFTX.
Mission and direction
Definium Therapeutics is a late-stage clinical biopharmaceutical company developing science-led, accessible psychedelic-based treatments for psychiatric and neurological disorders. The company applies scientific rigor to novel therapies with the goal of creating differentiated options that can deliver real relief for conditions such as anxiety, depression, PTSD, and autism-related social communication challenges, helping advance brain health and transform mental health care.
Company values
- Scientific rigor
- Patient impact
- Innovation
- Accessibility
- Collaboration
- Excellence
- Integrity
- Speed with quality